ロード中...
Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
Hepatocellular carcinoma is one of the most common cancers worldwide, and a leading cause of cancer-related death. Owing to unsatisfactory clinical outcomes under the current standard of care, there is a need to search for and identify novel and potent therapeutic targets to improve patient outcomes...
保存先:
| 出版年: | World J Gastroenterol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4223260/ https://ncbi.nlm.nih.gov/pubmed/25386075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i41.15269 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|